Ravi Upasani

Ravi joined Biomea Fusion as Senior Vice President of Intellectual Property in April 2021. He brings over 30 years of experience in Biotech and the Pharmaceutical industry. Ravi earned his Ph.D. in small molecule chemistry and his qualifications include a unique combination of extensive experience in medicinal chemistry and expertise in Intellectual Property. Prior to joining us, Ravi was with Protagonist Therapeutics as the Vice President of Intellectual Property. Previously, he held senior-level Intellectual Property positions at Pharmacyclics, Evotec, AG, and Renovis. In this capacity, Ravi was responsible for the management of IP functions, including the development and implementation of patent strategy; drafting and prosecution of patent applications and managing the company’s extensive patent portfolio. He is registered before the U.S. Patent and Trademark Office (USPTO) as a patent agent. Ravi has authored over 35 publications and is an inventor of more than 15 United States patents.